Individual vulnerability to addiction

Annals of the New York Academy of Sciences

Volumn 1216, Issue 1, 2011, Pages 73-85

  Swendsen, Joel ^a   Le Moal, Michel ^b  

^a CNRS   (France)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

Addiction; Comorbidity; Vulnerability

Indexed keywords

ADDICTION; ARTICLE; CLINICAL RESEARCH; COMORBIDITY; DEMOGRAPHY; IATROGENIC DISEASE; NEUROSCIENCE; PHENOTYPE; POLICY; PREFRONTAL CORTEX; PROPENSITY SCORE; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; SOCIAL STATUS; VULNERABLE POPULATION;

EID: 79251472090     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05894.x     Document Type: Article

References (120)

1. World Health Organization. 2009. Global health risks. Mortality and burden of diseases attributable to selected major risks. WHO Press. Geneva
2. World Health Organization. 2009. WHO report on the global tobacco epidemic. WHO Press. Geneva
3. Le Moal, M. 2010. Vulnerability factors in addiction disorders. In Encyclopedia of Behavioral Neuroscience. G. Koob, M. Le Moal & R. Thompson, Eds.: Online encyclopedia. Elsevier. Amsterdam
4. Anthony, J. C., L. A. Warner & R. C. Kessler 1994. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 2: 244-268.
5. Crum, R.M., Y.F. Chan, L.S. Chen, et al 2005. Incidence rates for alcohol dependence among adults: prospective data from the Baltimore Epidemiologic Catchment Area Follow-Up Survey, 1981-1996. J. Stud. Alcohol 66: 795-805.
6. Grant, B.F., F.S. Stinson & T.C. Harford 2001. Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-up. J. Substance Abuse. 13: 493-504.
7. Hasin, D.S., F.S. Stinson, E. Ogburn & B.F. Grant 2007. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 64: 830-842.
8. Kessler, R.C., P. Berglund, O. Demler, et al 2005. Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication. Arch. Gen. Psychiatry 62: 593-602.
9. Swendsen, J., K.P. Conway, L. Degenhardt, et al 2009. Sociodemographic risk factors for alcohol and drug dependence: the 10-year follow-up of the National Comorbidity Survey. Addiction 104: 1346-1355.
10. Warner, L.A., R.C. Kessler, M. Hughes, et al 1995. Prevalence and correlates of drug use and dependence in the Unites States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 52: 219-229.
11. Conway, K., J. Swendsen, B. Rounsaville & K. Merikangas 2002. Personality, drug of choice, and comorbid psychopathology among substance abusers. Drug Alcohol Depend. 65: 225-234.
12. Grant, B.F., F.S. Stinson, D.A. Dawson, et al 2004. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 61: 807-816.
13. Kessler, R.C., W.T. Chiu, O. Demler, & E.E. Walters 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62: 617-627.
14. Kessler, R, R. Crum, L. Warner, et al 1997. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch. Gen. Psychiatry 54: 313-321.
15. Merikangas, K.R., R. Mehta, B.E. Molnar, et al 1998. The comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology (I.C.P.E.). Addict. Behav. 23: 893-907.
16. Swendsen, J., K. Conway, B. Rounsaville, & K. Merikangas 2002. Are personality traits familial risk factors for substance use disorder? Results of a controlled family study. Am. J. Psychiatry. 159: 1760-1766.
17. Swendsen, J., K.P. Conway, L. Degenhardt, et al 2010. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addict. 105: 1117-1128.
18. Gelernter, J. & H.R. Kranzler 2009. Genetics of alcohol dependence. Hum. Genet. 126: 91-99.
19. Koob, G.F. & M. Le Moal 2006. Neurobiology of Addiction. 570 pp. Elsevier. Amsterdam
20. Koob, G.F. & E.P. Zorrilla 2010. Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Curr. Opin. Investig. Drugs. 11: 63-71.
21. Piazza, P.V., J.M. Deminière, M. Le Moal & H. Simon 1989. Factors that predict individual vulnerability to amphetamine self-administration. Science 245: 1511-1513.
22. Ahmed, S.H. & G.F. Koob 1998. Transition from moderate to excessive drug intake: change in hedonic set point. Science 282: 298-300.
23. Deroche-Gamonet, V., D. Belin & P.V. Piazza 2004. Evidence for addiction-like behavior in the rat. Science 305: 1014-1017.
24. Belin, D., A.C. Mar, J.W. Dalley, et al 2008. High impulsivity predicts the switch to compulsive cocaine-taking. Science 6;320: 1352-1355.
25. World Health Organization. 2008. Global burden of disease: 2004 update. Implementing Smoke-Free Environments. WHO Press. Geneva
26. Alegria, M., G. Canino, F.S. Stinson, et al 2006. Nativity and DSM-IV psychiatric disorders among Puerto Ricans, Cuban Americans, and non-Latino whites in the United States: results from the national epidemiologic survey on alcohol and related conditions. J. Clin. Psychiatry. 67: 56-65.
27. Grant, B.F., F.S. Stinson, D.S. Hasin, et al 2004. Immigration and lifetime prevalences of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry. 61: 1226-1233.
28. Sokol-Katz, J.S. & P.M. Ulbrich 1992. Family structure and adolescent risk-taking behavior: a comparison of Mexican, Cuban and Puerto Rican Americans. Int. J. Addict. 27: 1197-1209.
29. Vega, W.A., E. Alderete, B. Kolody, et al. 1998. Illicit drug use among Mexicans and Mexican American in California: the effects of gender and acculturation. Addiction. 93: 1839-1850.
30. Merikangas, K.R., K.P. Conway, J. Swendsen, et al 2009. Substance use and behaviour disorders in Puerto Rican youth: a migrant family study. J. Epidemiol. Community Health. 63: 310-316.
31. Burnam, M., A Hough, L. Richard, et al 1987. Acculturation and lifetime prevalence of psychiatric disorders among Mexican Americans in Los Angeles. J. Health Soc. Behav. 28: 89-102.
32. Merikangas, K.R., J.P. He, M. Burstein, et al 2010. Lifetime prevalence of mental disorders in U.S. adolescent. J. Am. Acad. Child Adolesc. Psychiatry 49: 980-989.
33. Grant, B.F., & D.A. Dawson 1998. Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst. Abuse 10: 163-173.
34. Pitkanen, T., A.L. Lyyra & L. Pulkkinen 2005. Age of onset of drinking and the use of alcohol in adulthood: a follow-up study from age 8-42 for females and males. Addiction 100: 652-661.
35. Crews, F., J. He & C. Hodge 2007. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol. Biochem. Behav. 86: 189-199.
36. Toga, A.W., P.M. Thompson & E.R. Sowell 2006. Mapping brain maturation. Trends Neurosci. 29: 148-159.
37. Spear, L.P. 2000. The adolescent brain and age-related behavioral manifestations. Neurosci. Biol. Behav. Rev. 24: 417-463.
38. Rosenzweig, M.R. & E.L. Bennett 1996. Psychobiology of plasticity: effects of training and experience on brain and behavior. Behav. Brain Res. 78: 57-65.
39. Adriani, W., D. Giannakopoulou, Z. Bokulic et al 2006. Response to novelty, social and self-control behaviors, in rats exposed to neonatal anoxia: modulatory effects of an enriched environment. Psychopharmacology 184: 155-165.
40. Biglan, A., C.W. Metzler, R. Wirt et al 1990. Social and behavioral factors associated with high-risk sexual behavior among adolescents. J. Behav. Med. 13: 245-261.
41. Kandel, D.B. & R. Jessor 2002. The gateway hypothesis revisited. In Stages and Pathways of Drugs Involvement: Examining the Gateway Hypothesis. D.B. Kandel, Ed.: 365-372. Cambridge University Press. New York
42. Degenhardt, L., W.T. Chiu, K. Conway, et al 2009. Does the 'gateway' matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication. Psychol. Med. 39: 157-167.
43. Grant, B. F., R. B. Goldstein, S. P. Chou, et al 2009. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol. Psychiatry. 14: 1051-1066.
44. Kalaydjian, A., J. Swendsen, W.T. Chiu, et al 2009. Sociodemographic predictors of transitions across stages of alcohol use, disorders and remission in the National Comorbidity Survey-Replication. Compr. Psychiatry. 50: 299-306.
45. Fox, H.C., K.A. Hong, P. Paliwal, et al 2008. Altered levels of sex and stress steroid hormones assessed daily over a 28-day cycle in early abstinent cocaine-dependent females. Psychopharmacology 195: 527-536.
46. Hernandez-Avila, C.A., B.J. Rounsaville & H.R. Kranzler 2004. Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend. 74: 265-272.
47. Najavits, L.M., R.D. Weiss & S.R. Shaw 1997. The link between substance abuse and posttraumatic stress disorder in women-a research review. Am. J. Addict. 6: 273-283.
48. Dreher, JC., P.J. Schmidt, P. Kohn et al 2007. Menstrual cycle phase modulates reward-related neural function in women. Proc. Natl. Acad. Sci. USA 104: 2465-2470.
49. Crome, I.B. 1997. Gender differences in substance misuse and psychiatric comorbidity. Curr. Opin. Psychiatry 10: 194-198.
50. Carroll, M.E., W.J. Lynch, M.E. Roth, et al 2004. Sex and estrogen influence drug abuse. Trends Pharmacol. Sci. 25: 273-279.
51. Larson, E.B., M.E. Roth, J.J. Anker & M.E. Carroll 2005. Effect of short- versus. long-term estrogen on reinstatement of cocaine-seeking behavior in female rats. Pharmacol. Biochem. Behav. 82: 98-108.
52. Dazzi, L., E. Seu, G. Cherchi, et al 2007. Estrous cycle-dependent changes in basal and ethanol-induced activity of cortical dopaminergic neurons in the rat. Neuropsychopharmacology 32: 892-901.
53. Chambless, D., J. Cherney, G. Caputo & B. Rheinstein 1987. Anxiety disorders and alcoholism: a study with inpatient alcoholics. J. Anx. Dis. 1: 29-40.
54. Grant, B. F. & T. C. Harford 1995. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend. 39: 197-206.
55. Helzer, J. & T. Pryzbeck 1988. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J. Stud. Alcohol 49: 219-224.
56. Penick, E., B. Powell, E. Nickel, et al 1994. Co-morbidity of lifetime psychiatric disorder among male alcoholic patients. Alcohol: Clin. Exp. Res. 18: 1289-1293.
57. Regier, D.A., M.E. Farmer, D.S. Rae, et al 1990. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA. 264: 2511-2518.
58. Schuckit, M.A. & V. Hesselbrock 1994. Alcohol dependence and anxiety disorders: what is the relationship? Am. J. Psychiatry 151: 1723-1734.
59. Conger, J.J. 1956. Reinforcement theory and the dynamics of alcoholism. Quarter. J. Stud. Alcohol, 17: 296-305.
60. Khantzian, E.J. 1985. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry 142: 1259-1264.
61. Khantzian, E.J. 1997. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry 4: 231-244.
62. Anthenelli, R.M. & M.A. Schuckit 1993. Affective and anxiety disorders and alcohol and drug dependence: diagnosis and treatment. J. Addict. Dis. 12: 73-87.
63. Johnson, E.O. & L. Schultz 2005. Forward telescoping bias in reported age of onset: an example from cigarette smoking. Int. J. Method. Psychiatry Res. 14: 119-129.
64. Breslau, N., E. L. Peterson, L. R. Schultz, et al 1998. Major depression and stages of smoking: a longitudinal investigation. Arch. Gen. Psychiatry 55: 161-166.
65. Merikangas, K.R., R. Herrell, J. Swendsen, et al 2008. Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study. Arch. Gen;. Psychiatry. 65: 47-52.
66. Rohde, P., C. W. Kahler, P. M. Lewinsohn & R. A. Brown 2004. Psychiatric disorders, familial factors, and cigarette smoking: II. Associations with progression to daily smoking. Nicotine. Tob. Res. 6: 119-132.
67. Rohde, P., P. M. Lewinsohn, R. A. Brown, et al 2003. Psychiatric disorders, familial factors and cigarette smoking: I. Associations with smoking initiation. Nicotine. Tob. Res. 5: 85-98.
68. Zimmermann, P., H. U. Wittchen, M. Höfler, et al 2003. Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults. Psychol. Med. 33: 1211-1222.
69. Kendler, K.S., C.A. Prescott, J. Myers & M.C. Neale 2003. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry. 60: 929-937.
70. Merikangas, K.R., J.J. Li, B. Stipelman, et al 2009. The familial aggregation of cannabis use disorders. Addiction 104: 622-629.
71. Preisig, M., B.T. Fenton, D.E. Stevens & K.R. Merikangas 2001. Familial relationship between mood disorders and alcoholism. Compr. Psychiatry. 42: 87-95.
72. Swendsen, J. 2010. Psychiatric and Substance Use Disorder Comorbidity. In G. Koob, M. Le Moal & R. Thompson (Eds) Encyclopedia of Behavioral Neuroscience. Online encyclopedia, Elsevier. Amsterdam
73. Johnson, E.I., O. Grondin, M. Barrault, et al 2009. Computerized ambulatory monitoring in psychiatry: a multi-site collaborative study of acceptability, compliance, and reactivity. Int. J. Method. Psychiatr. Res. 18: 48-57.
74. Shiffman, S. 2009. Ecological momentary assessment (EMA) in studies of substance use. Psychol. Assess. 21: 486-497.
75. Allen, T.J., F.G. Moeller, H.M. Rhoades & D.R. Cherek 1998. Impulsivity and history of drug dependence. Drug Alcohol Depend. 50: 137-145.
76. Fisher, L.A., J.W. Elias & K. Ritz 1998. Predicting relapse to substance abuse as a function of personality dimensions. Alcohol Clin. Exp. Res. 22: 1041-1047.
77. Graham, J.R. & V.E. Strenger 1988. MMPI characteristics of alcoholics: a review. J. Consult. Clin. Psychol. 56: 197-205.
78. Martin, E.D. & K. Sher 1994. Family history of alcoholism, alcohol use disorders and the five-factor model of personality. J. Stud. Alcohol 55: 81-90.
79. Merikangas, K.R, J. Swendsen, M. Preisig & R.H. Chasen 1998. Temperament and psychopathology: results of a controlled family study. J. Affect. Dis. 51: 63-74.
80. Caspi, A., D Begg, N. Dickson, et al 1997. Personality differences predict health-risk behaviors in young adulthood: evidence from a longitudinal study. J. Pers. Soc. Psychol. 73: 1052-1063.
81. Cloninger, C.R., S. Sigvardsson & M. Bohman 1988. Childhood personality predicts alcohol abuse in young adults. Alcohol Clin. Exp. Res. 12: 494-505.
82. Jones, M.C. 1968. Personality correlates and antecedents of drinking patterns in adult males. J. Consul. Clin. Psychol. 32: 2-12.
83. Loper R.G., M.L. Kammeier & H. Haffmann 1973. MMPI characteristics of college freshmen males who later became alcoholics. J. Abnorm. Psychol. 82: 159-162.
84. Huizink, A.C., E.J. Mulder & J.K. Buitelaar 2004. Prenatal stress and risk for psychopathology: specific effects or induction of general susceptibility? Psychol. Bull. 130: 115-142.
85. Seckl, J.R. & M.J. Meaney 2006. Glucocorticoid "programming" and PTSD risk. Ann. NY Acad. Sci. 1071: 351-378.
86. Weinstock, M. 2005. The potential influence of maternal stress hormones on development and mental health of the offspring. Brain Behav. Immun. 19: 296-308.
87. Kippin, T.E., K.K. Szumlinski, Z. Kapasova, et al 2008. Prenatal stress enhances responsiveness to cocaine. Neuropsychopharmacology 33: 769-782.
88. Kofman, O. 2002. The role of prenatal stress in the etiology of developmental behavioural disorders. Neurosci. Biobehav. Rev. 26: 457-470.
89. Welberg, L.A., & J.R. Seckl 2001. Prenatal stress, glucocorticoids and the programming of the brain. J. Neuroendocrinol. 13: 113-128.
90. Vallée, M., W. Mayo, F. Dellu, et al 1997. Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion. J. Neurosci. 17: 2626-2636.
91. Piazza, P.V. & M. Le Moal 1996. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 36: 359-378.
92. Piazza, P.V. & M. Le Moal 1998. The role of stress in drug self-administration. Trends Pharmacol. Sci. 19: 67-74.
93. Deminière, J. M., P. V. Piazza, G. Guegan, et al 1992. Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers. Brain Res. 586: 135-139.
94. Henry, C., G. Guegant, M. Cador, et al 1995. Prenatal stress in rats facilitates amphetamine-induced sensitization and induces long-lasting changes in dopamine receptors in the nucleus accumbens. Brain Res. 685: 179-186.
95. Barbazanges, A., M. Vallée, W. Mayo et al 1996. Early and later adoptions have different long-term effects on male rat offspring. J. Neurosci. 16: 7783-7790.
96. Maccari, S., P.V. Piazza, M. Kabbaj, et al 1995. Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. J. Neurosci. 15: 110-116.
97. Gordon, H.W. 2002. Early environmental stress and biological vulnerability to drug abuse. Psychoneuroendocrinology 27: 115-126.
98. Higley, J.D., M. Hasert, S. Suomi & M. Linnoila 1991. Nonhuman primate model of alcohol abuse: effects of early experience, personality, and stress on alcohol consumption. Proc. Natl. Acad. Sci. USA 88: 7261-7265.
99. Barr, C.S., T.K. Newman, M. Schwandt, et al 2004. Sexual dichotomy of an interaction between early adversity and the serotonin transporter gene promoter variant in rhesus macaques. Proc. Natl. Acad. Sci. USA 101: 12358-12363.
100. Piazza, P.V., S. Maccari, J.M. Deminière, et al 1991. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. USA 88: 2088-2092.
101. Blanc, G., D. Hervé, H. Simon, et al 1980. Response to stress of mesocortico-frontal dopaminergic neurones in rats after long-term isolation. Nature 284: 265-267.
102. Green, T.A., B.J. Gehrke & M.T. Bardo 2002. Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed and progressive-ratio schedules. Psychopharmacology 162: 373-378.
103. Bardo, M.T., J.E. Klebaur, J.M. Valone & C. Deaton 2001. Environmental enrichment decreases intravenous self-administration of amphetamine in female and male rats. Psychopharmacology 155: 278-284.
104. Howes, S.R., J.W. Dalley, C.H. Morrison, et al 2000. Leftward shift in the acquisition of cocaine self-administration in isolation-reared rats: relationship to extracellular levels of dopamine, serotonin and glutamate in the nucleus accumbens and amygdala-striatal FOS expression. Psychopharmacology 151: 55-63.
105. Kosten, T.A., X.Y. Zhang & P. Kehoe 2006. Heightened cocaine and food self-administration in female rats with neonatal isolation experience. Neuropsychopharmacology 31: 70-76.
106. Crabbe, J.C. 2002. Genetic contributions to addiction. Annu. Rev. Psychol. 53: 435-462.
107. Goldman, D., G. Oroszi & F. Ducci 2005. The genetics of addictions: uncovering the genes. Nat. Rev. Gen. 6: 521-532.
108. Uhl, G.R. & R.W. Grow 2004. The burden of complex genetics in brain disorders. Arch. Gen. Psychiatry 61: 223-229.
109. Rutter, M., T.E. Moffit & A. Caspi 2006. Gene-environment interplay and psychopathology: multiple varieties but real effects. J. Child. Psychol. Psychiat. 47: 226-261.
110. Kreek, M.J., D.A. Nielsen, E.R. Butelman & K.S. LaForge 2005. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nature. Neurosci. 8: 1450-1457.
111. Shaffer, H.J., D.A. LaPlante, R.A. LaBrie, et al 2004. Toward a syndrome model of addiction: multiple expressions, common etiology. Harv. Rev. Psychiatry. 12: 367-374.
112. Tsankova, N., W. Renthal, A. Kumar & E.J. Nestler 2007. Epigenetic regulation in psychiatric disorders. Nature. Rev. Neurosci. 8: 1-23.
113. Sasaki, H. & Y. Matsui 2008. Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nature. Rev. Genetics 9: 129-140.
114. Jirtle, R.L. & M.K. Skinner 2007. Environmental epigenomics and disease susceptibility. Nature. Rev. Genetics 8: 253-262.
115. Cole, S.W., L.C. Hawkley, J.M. Arevalo, et al 2007. Social regulation of gene expression in human leukocytes. Genome. Biol. 8: R189.
116. McGowan, P.O., A. Sasaki, A.C. D'Alessio, et al 2009. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12: 342-348.
117. Danese, A., C.M. Pariante, A. Caspi, et al 2007. Childhood maltreatment predicts adult inflammation in a life-course study. Proc. Natl. Acad. Sci. U S A. 104: 1319-1324.
118. Miller, G.E., E. Chen, A.K. Fok, et al 2009. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc. Natl. Acad. Sci. U S A. 106: 14716-14721.
119. Li, L., C. Power, S. Kelly, et al 2007. Life-time socio-economic position and cortisol patterns in mid-life. Psychoneuroendocrinology. 32: 824-833.
120. Miller, G., E. Chen & S.W. Cole 2009. Health psychology: developing biologically plausible models linking the social world and physical health. Annu. Rev. Psychol. 60: 501-524.